US2007141171A1PendingUtilityA1
Novel composition and method for the treatment of hypertension
Est. expiryMay 30, 2023(expired)· nominal 20-yr term from priority
A61K 31/198A61K 33/04A61K 33/32A23L 33/16A61K 33/06A61K 31/401A23V 2002/00A23L 33/175A61P 9/02A61K 31/7048A61K 31/375A61K 33/34A23L 33/105A61K 45/06A61K 36/82A61K 36/752A61K 31/221A61K 31/352
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides for a composition and method of treatment and prevention of hypertension and its restulting complication comprising the step of administering to a patient a therapeutically-effective amount of Quercetin or Quercetin Glycoside and Epican Forte in therapeutic proportions.
Claims
exact text as granted — not AI-modified1 . A composition for use in treatment of hypertension in a patient suffering from hypertension or its side effect, the composition consisting of one or more pharmaceutical excipients and a therapeutically˜effective amount of Quercetin or a glycoside derivative thereof, L-Lysine, 1-Proline, L-Arginine, vitanin C, magnesium standard green tea extract containing 80% polyphenols, N-acetyl-cysteine, selenium, copper, and manganese.
2 . The composition of claim 1 wherein the amount of Quercetin or Quercetin glycoside derivative is in the range from about 100 mg to about 15 grams.
3 . The composition of claim 1 wherein the amount of Quercetin or Quercetin glycoside derivative is in the range from about 1 gram to about 10 grams.
4 . The composition of claim 1 wherein the amount of L-Lysine is 1000 mg, the amount of L-Proline is 750 mg, the amount of L-Arginine is 500 mg, the amount of vitamin C is 710 mg, the amount of magnesium is 50 mg, the amount of standard green tea extract containing 80% polyphenols is 1000 mg, tile amount of N-acetyl-cysteine is 200 mg the amount of selenium is 30 mcg(micrograms), the amount of copper is 2 mg, and the amount of manganese is 1 mg.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.